Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Hepatitis C

Free Subscription Articles published in J Med Virol Retrieve available abstracts of 90 articles: HTML format Text format

Single Articles

March 2012
1. HAYASHI K , Katano Y, Kuzuya T, Tachi Y, et al
   Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.
   J Med Virol. 2012;84:438-44.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. CHARY A , Winters MA, Eisen R, Knight TH, et al
   Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
   J Med Virol. 2012;84:431-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   February 2012
3. BLACKARD JT , Ma G, Welge JA, Martin CM, et al
   Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization.
   J Med Virol. 2012;84:242-52.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. SHAH DP , Grimes CZ, Brown E, Hwang LY, et al
   Demographics, socio-behavioral factors, and drug use patterns: What matters in spontaneous HCV clearance?
   J Med Virol. 2012;84:235-41.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SASAYAMA M , Shoji I, Adianti M, Jiang DP, et al
   A point mutation at Asn-534 that disrupts a conserved N-glycosylation motif of the E2 glycoprotein of hepatitis C virus markedly enhances the sensitivity to antibody neutralization.
   J Med Virol. 2012;84:229-34.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. KARATAPANIS S , Tsoplou P, Papastergiou V, Vasiageorgi A, et al
   Hepatitis C virus genotyping in Greece: Unexpected high prevalence of genotype 5a in a Greek island.
   J Med Virol. 2012;84:223-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
7. TOYODA H , Kumada T, Tada T, Hayashi K, et al
   Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b.
   J Med Virol. 2012;84:61-70.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. SILVA GF , Grotto RM, Verdichio-Moraes CF, Corvino SM, et al
   Human platelet antigen genotype is associated with progression of fibrosis in chronic hepatitis C.
   J Med Virol. 2012;84:56-60.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
9. DEMETRIOU VL , Kostrikis LG
   Near-full genome characterization of unclassified hepatitis c virus strains relating to genotypes 1 and 4.
   J Med Virol. 2011;83:2119-27.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. NJOUOM R , Lavoie M, Foupouapouognigni Y, Frost E, et al
    Transmission of Hepatitis C virus among spouses in Cameroon and the Central African Republic.
    J Med Virol. 2011;83:2113-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
11. GASIM GI , Hamdan HZ, Hamdan SZ, Adam I, et al
    Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan.
    J Med Virol. 2011 Nov 3. doi: 10.1002/jmv.22256.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. WU S , Liu Y, Cheng L, Yin B, et al
    Clinical evaluation of the signal-to-cutoff ratios of hepatitis C virus antibody screening tests used in China.
    J Med Virol. 2011;83:1930-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. FURUI Y , Hoshi Y, Murata K, Ito K, et al
    Prevalence of Amino acid mutation in hepatitis C virus core region among Japanese volunteer blood donors.
    J Med Virol. 2011;83:1924-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
14. DAI S , Shen Z, Zha Z, Leng R, et al
    Seroprevalence of HIV, syphilis, and hepatitis C virus in the general population of the Liangshan Prefecture, Sichuan Province, China.
    J Med Virol. 2011 Oct 25. doi: 10.1002/jmv.22214.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. FERREIRA AD , Perez RD, Ferraz ML, Lewis-Ximenez LL, et al
    Acute hepatitis C in Brazil: Results of a national survey.
    J Med Virol. 2011;83:1738-1743.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. YOKOZAKI S , Katano Y, Hayashi K, Ishigami M, et al
    Mutations in two PKR-binding domains in chronic hepatitis C of genotype 3a and correlation with viral loads and interferon responsiveness.
    J Med Virol. 2011;83:1727-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
17. CICCOZZI M , Zehender G, Cento V, Presti AL, et al
    Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users.
    J Med Virol. 2011;83:1565-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. TOYODA H , Kumada T, Hayashi K, Honda T, et al
    Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene.
    J Med Virol. 2011;83:1559-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. ABE H , Hayes CN, Ochi H, Tsuge M, et al
    Inverse association of IL28B genotype and liver mRNA expression of genes promoting or suppressing antiviral state.
    J Med Virol. 2011;83:1597-607.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
20. YAHOO N , Sabahi F, Shahzamani K, Malboobi MA, et al
    Mutations in the E2 and NS5A regions in patients infected with hepatitis C virus genotype 1a and their correlation with response to treatment.
    J Med Virol. 2011;83:1332-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
21. VEJBAESYA S , Nonnoi Y, Tanwandee T, Srinak D, et al
    Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.
    J Med Virol. 2011 Jul 13. doi: 10.1002/jmv.22153.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. ACKERMAN Z , Pappo O, Ben-Dov IZ
    The prognostic value of changes in serum ferritin levels during therapy for hepatitis C virus infection.
    J Med Virol. 2011;83:1262-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. LIANG CC , Liu CH, Lin YL, Liu CJ, et al
    Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy.
    J Med Virol. 2011;83:1212-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. TOYODA H , Kumada T, Tada T, Kawaguchi T, et al
    Impact of genetic polymorphisms near the IL28B gene and amino acid substitutions in the hepatitis C virus core region on interferon sensitivity/resistance in patients with chronic hepatitis C.
    J Med Virol. 2011;83:1203-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. KIM JY , Won JE, Jeong SH, Park SJ, et al
    Acute hepatitis C in Korea: Different modes of infection, high rate of spontaneous recovery, and low rate of seroconversion.
    J Med Virol. 2011;83:1195-202.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. CHAN DP , Lee SS, Lee KC
    The effects of widespread methadone treatment on the molecular epidemiology of hepatitis C virus infection among injection drug users in Hong Kong.
    J Med Virol. 2011;83:1187-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. YANG RR , Gui X, Chen XY, Zhu Y, et al
    Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    J Med Virol. 2011;83:1159-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
28. AKUTA N , Suzuki F, Hirakawa M, Kawamura Y, et al
    Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.
    J Med Virol. 2011;83:1016-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. PASCARELLA S , Clement S, Guilloux K, Conzelmann S, et al
    Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: Comparison between different genotypes and core protein sequence analysis.
    J Med Virol. 2011;83:1005-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. BOKHARAEI-SALIM F , Keyvani H, Monavari SH, Alavian SM, et al
    Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease.
    J Med Virol. 2011;83:989-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. HASHIMOTO Y , Ochi H, Abe H, Hayashida Y, et al
    Prediction of response to peginterferon-alfa-2b plus ribavirin therapy in Japanese patients infected with hepatitis C virus genotype 1b.
    J Med Virol. 2011;83:981-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. TELAN EF , Samonte GM, Abellanosa-Tac-An IP, Alesna ET, et al
    The early phase of an HIV epidemic in a population exposed previously to HCV in the Philippines.
    J Med Virol. 2011;83:941-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. BOLCIC F , Jones LR, Laufer N, Quarleri J, et al
    Molecular characterization of hepatitis C virus genotype 4 sequences in HIV-coinfected patients from Argentina.
    J Med Virol. 2011;83:935-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. BARTH RE , Huijgen Q, Tempelman HA, Mudrikova T, et al
    Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.
    J Med Virol. 2011;83:929-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
35. ROLFE KJ , Curran MD, Alexander GJ, Woodall T, et al
    Spontaneous loss of hepatitis C virus RNA from serum is associated with genotype 1 and younger age at exposure.
    J Med Virol. 2011 May 26. doi: 10.1002/jmv.22115.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. DUAN L , Lei P, Yumei X, Xiaoping X, et al
    Prediction and identification-based prediction of Chinese hepatitis C Viral-specific cytotoxic T lymphocyte epitopes.
    J Med Virol. 2011 May 26. doi: 10.1002/jmv.22053.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. NAKAMUTA M , Fujino T, Yada R, Aoyagi Y, et al
    Expression profiles of genes associated with viral entry in HCV-infected human liver.
    J Med Virol. 2011;83:921-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. MARTRO E , Valero A, Jordana-Lluch E, Saludes V, et al
    Hepatitis C virus sequences from different patients confirm the existence and transmissibility of subtype 2q, a rare subtype circulating in the metropolitan area of Barcelona, Spain.
    J Med Virol. 2011;83:820-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. D'HEYGERE F , George C, Van Vlierberghe H, Decaestecker J, et al
    Efficacy of interferon-based antiviral therapy in patients with chronic hepatitis C infected with genotype 5: A meta-analysis of two large prospective clinical trials.
    J Med Virol. 2011;83:815-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. KWON JH , Jeong SH, Kim JW, Bang SM, et al
    Case report: A case of light chain deposition disease involving liver and stomach with chronic hepatitis C virus infection and hepatocellular carcinoma.
    J Med Virol. 2011;83:810-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. TAKANO T , Kohara M, Kasama Y, Nishimura T, et al
    Translocase of outer mitochondrial membrane 70 expression is induced by hepatitis C virus and is related to the apoptotic response.
    J Med Virol. 2011;83:801-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. SAKAMOTO N , Nakagawa M, Tanaka Y, Sekine-Osajima Y, et al
    Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b.
    J Med Virol. 2011;83:871-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
43. HE Y , Zhang J, Zhong L, Chen X, et al
    Prevalence of and risk factors for hepatitis C virus infection among blood donors in Chengdu, China.
    J Med Virol. 2011;83:616-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. CALADO RA , Rocha MR, Parreira R, Piedade J, et al
    Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.
    J Med Virol. 2011;83:608-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. OPALEYE OO , Fagbami AH, Lalremruata A, Kun JF, et al
    Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
    J Med Virol. 2011;83:710-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
46. KUROSAKI M , Sakamoto N, Iwasaki M, Sakamoto M, et al
    Sequences in the interferon sensitivity-determining region and core region of hepatitis C virus impact pretreatment prediction of response to PEG-interferon plus ribavirin: Data mining analysis.
    J Med Virol. 2011;83:445-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. NICOT F , Alric L, Barange K, Metivier S, et al
    Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.
    J Med Virol. 2011;83:437-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. DENCS A , Hettmann A, Martyin T, Jekkel C, et al
    Phylogenetic investigation of nosocomial transmission of hepatitis C virus in an oncology ward.
    J Med Virol. 2011;83:428-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. INOUE Y , Hiramatsu N, Oze T, Yakushijin T, et al
    Amino acid substitution in the core protein has no impact on relapse in hepatitis C genotype 1 patients treated with peginterferon and ribavirin.
    J Med Virol. 2011;83:419-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
50. ABREHA T , Woldeamanuel Y, Pietsch C, Maier M, et al
    Genotypes and viral load of hepatitis C virus among persons attending a voluntary counseling and testing center in Ethiopia.
    J Med Virol. 2011 Feb 23. doi: 10.1002/jmv.21788.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. FARAG NH , Rashed HA, Hassan M, Darweesh A, et al
    Hepatitis C infection, Cognition, and inflammation in an Egyptian sample.
    J Med Virol. 2011;83:261-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
52. TOYODA H , Kumada T, Kiriyama S, Tanikawa M, et al
    Outcome in partial early virologic responders to combination therapy with peginterferon and ribavirin in patients infected with hepatitis C virus genotype 1b.
    J Med Virol. 2011;83:101-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
53. SHIMOZUMA Y , Ito T, Inokuchi M, Uchikoshi M, et al
    Reactivation of epstein-barr virus in B cells of patients with chronic hepatitis C.
    J Med Virol. 2010;82:2064-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. SHIMOZUMA Y , Ito T, Inokuchi M, Uchikoshi M, et al
    Reactivation of epstein-barr virus in B cells of patients with chronic hepatitis C.
    J Med Virol. 2010;82:2064-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. NATARAJAN V , Kottilil S, Hazen A, Adelsberger J, et al
    HCV in peripheral blood mononuclear cells are predominantly carried on the surface of cells in HIV/HCV co-infected individuals.
    J Med Virol. 2010;82:2032-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. HALFON P , Perusat S, Bourliere M, Bronowicki JP, et al
    Neutralizing antibodies to interferon-alpha and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-alpha-2a and ribavirin (ANRS HC16 GAMMATRI substudy*).
    J Med Virol. 2010;82:2027-2031.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
57. MORA MV , Romano CM, Gomes-Gouvea MS, Gutierrez MF, et al
    Molecular characterization, distribution, and dynamics of hepatitis C virus genotypes in blood donors in Colombia.
    J Med Virol. 2010;82:1889-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. ELKADY A , Tanaka Y, Kurbanov F, Sugauchi F, et al
    Performance of two Real-Time RT-PCR assays for quantitation of hepatitis C virus RNA: evaluation on HCV genotypes 1-4.
    J Med Virol. 2010;82:1878-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. ERIKSEN MB , Jorgensen LB, Krarup H, Laursen AL, et al
    Molecular and epidemiological profiles of hepatitis C virus genotype 4 in Denmark.
    J Med Virol. 2010;82:1869-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. ASKAR E , Ramadori G, Mihm S
    Toll-like receptor 7 rs179008/Gln11Leu gene variants in chronic hepatitis C virus infection.
    J Med Virol. 2010;82:1859-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
61. EL-ATTAR LM , Partidos CD, Howard CR
    A peptide mimotope of hepatitis C virus E2 protein is immunogenic in mice and block human anti-HCV sera.
    J Med Virol. 2010;82:1655-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. LARSEN C , Bousquet V, Delarocque-Astagneau E, Pioche C, et al
    Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
    J Med Virol. 2010;82:1647-1654.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. FRANCOIS C , Descamps V, Brochot E, Bernard I, et al
    Relationship between the hepatitis C viral load and the serum interferon concentration during the first week of peginterferon-alpha-2b-ribavirin combination therapy.
    J Med Virol. 2010;82:1640-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. MOSSNER BK , Skamling M, Jorgensen TR, Georgsen J, et al
    Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users.
    J Med Virol. 2010;82:1635-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
65. CASTILLO I , Bartolome J, Quiroga JA, Barril G, et al
    Diagnosis of occult hepatitis C without the need for a liver biopsy.
    J Med Virol. 2010;82:1554-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. SATOH K , Takahashi H, Matsuda C, Tanaka T, et al
    Natural killer cells target HCV core proteins during the innate immune response in HCV transgenic mice.
    J Med Virol. 2010;82:1545-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. TOYODA H , Kumada T, Kiriyama S, Tanikawa M, et al
    An early viral response to standard interferon-alpha identifies resistance to combination therapy with peginterferon and ribavirin in patients infected by HCV genotype 1.
    J Med Virol. 2010;82:1537-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
68. SHEN T , Chen X, Chen Y, Xu Q, et al
    Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection.
    J Med Virol. 2010;82:1152-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. RACHLINE A , Palmer P, Simon F, Molina JM, et al
    Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with HIV.
    J Med Virol. 2010;82:1150-1.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. ROSSO R , Di Biagio A, Mikulska M, Nicco E, et al
    Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally.
    J Med Virol. 2010;82:1110-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
71. SANJO M , Saito T, Ishii R, Nishise Y, et al
    Secondary structure of the amino-terminal region of HCV NS3 and virological response to pegylated interferon plus ribavirin therapy for chronic hepatitis C.
    J Med Virol. 2010;82:1364-1370.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. SEREMBA E , Ocama P, Opio CK, Kagimu M, et al
    Poor performance of hepatitis C antibody tests in hospital patients in Uganda.
    J Med Virol. 2010;82:1371-1378.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. TANIMOTO T , Cuong NH, Ishizaki A, Chung PT, et al
    Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam.
    J Med Virol. 2010;82:1355-1363.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
74. CROSS TJ , Quaglia A, Nolan J, Hughes S, et al
    Do steatosis and steatohepatitis impact on sustained virological response (SVR) rates in patients receiving pegylated interferon and ribavirin for chronic hepatitis C infection?
    J Med Virol. 2010;82:958-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. VALVA P , De Matteo E, Galoppo MC, Gismondi MI, et al
    Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis.
    J Med Virol. 2010;82:949-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
76. WINTERS MA , Chary A, Eison R, Asmuth D, et al
    Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co-infected patients.
    J Med Virol. 2010;82:791-798.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. SHUKLA P , Faulk KN, Emerson SU
    The entire core protein of HCV JFH1 is required for efficient formation of infectious JFH1 pseudoparticles.
    J Med Virol. 2010;82:783-790.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
78. BARRIL G , Bartolome J, Sanz P, Buoncristiani E, et al
    Effect of hemodialysis schedules and membranes on hepatocyte growth factor and hepatitis C virus RNA levels.
    J Med Virol. 2010;82:763-767.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. LEVAST M , Larrat S, Thelu MA, Nicod S, et al
    Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin.
    J Med Virol. 2010;82:747-754.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. MORIYA K , Miyoshi H, Shinzawa S, Tsutsumi T, et al
    Hepatitis C virus core protein compromises iron-induced activation of antioxidants in mice and HepG2 cells.
    J Med Virol. 2010;82:776-792.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. FABRIZI F , Dixit V, Messa P, Martin P, et al
    Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials.
    J Med Virol. 2010;82:768-775.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
82. AKUTA N , Suzuki F, Hirakawa M, Kawamura Y, et al
    Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin.
    J Med Virol. 2010;82:575-582.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. MEFFRE C , Le Strat Y, Delarocque-Astagneau E, Dubois F, et al
    Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors.
    J Med Virol. 2010;82:546-555.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. LEE S , Watson MW, Flexman JP, Cheng W, et al
    Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alphaand ribavirin therapy.
    J Med Virol. 2010;82:568-574.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. CANTALOUBE JF , Gallian P, Bokilo A, Jordier F, et al
    Analysis of hepatitis C virus strains circulating in Republic of the Congo.
    J Med Virol. 2010;82:562-567.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. SHIOGAMA K , Teramoto H, Morita Y, Mizutani Y, et al
    Hepatitis C virus infection in a Japanese leprosy sanatorium for the past 67 years.
    J Med Virol. 2010;82:556-561.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. ANTONELLI A , Ferri C, Ferrari SM, Ghiri E, et al
    High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia.
    J Med Virol. 2010;82:297-303.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
88. ARASE Y , Suzuki F, Suzuki Y, Akuta N, et al
    Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus.
    J Med Virol. 2010;82:390-395.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. BRANCO C , Esteves A, Piedade J, Parreira R, et al
    A new genotype 2 subcluster identified among GBV-C strains circulating in the Lisbon metropolitan area of Portugal.
    J Med Virol. 2010;82:452-459.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2009
90. WANG C , Heim A, Schlaphoff V, Suneetha PV, et al
    Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
    J Med Virol. 2009;81:2079-2088.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from F. Hoffmann-La Roche.

Amedeo is a Flying Publisher website.    Design: